Modeling of Neutropenia in the Setting of Autologous Stem Cell Transplant with Single, High Dose Chemotherapy and G-CSF

被引:0
|
作者
Irby, Donald J. [1 ]
Cho, Yu Kyoung [1 ]
Badawi, Mohamed [1 ]
Dauki, Anees [1 ]
Hofmeister, Craig C. [2 ]
Mould, Diane R. [2 ]
Phelps, Mitch A. [1 ]
机构
[1] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Emory Univ, Sch Med, Dept Med Hematol Oncol, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
M-090
引用
收藏
页码:S43 / S43
页数:1
相关论文
共 50 条
  • [31] Randomized comparison of G-CSF versus GM-CSF plus high dose chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora, M
    Burns, LJ
    Barker, JN
    Miller, JF
    Olujohungbe, AB
    Weisdorf, DJ
    BLOOD, 2002, 100 (11) : 109A - 110A
  • [32] Does Use of Biosimilar G-CSF Change Plerixafor Utilization during Stem Cell Mobilization for Autologous Stem Cell Transplant?
    Abdallah, Nadine
    Kim, Seongho
    Alavi, Asif
    Ayash, Lois
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    BLOOD, 2018, 132
  • [33] A COMPARISON OF EFFICACY OF GM-CSF VERSUS G-CSF IN THE THERAPEUTIC SETTING OF CHEMOTHERAPY-INDUCED NEUTROPENIA
    MILLER, JA
    BEVERIDGE, RA
    BLOOD, 1994, 84 (10) : A22 - A22
  • [34] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    Kaul, E.
    Shah, G.
    Chaulagain, C.
    Comenzo, R. L.
    BONE MARROW TRANSPLANTATION, 2014, 49 (09) : 1233 - 1233
  • [35] Outcomes of G-CSF alone vs G-CSF with upfront plerixafor vs G-CSF/chemotherapy for collection of autologous stem cells in patients with multiple myeloma.
    Talamo, Giampaolo
    George, Melissa
    Ehmann, W. Christopher
    Drabick, Joseph J.
    Mineishi, Shin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    E Kaul
    G Shah
    C Chaulagain
    R L Comenzo
    Bone Marrow Transplantation, 2014, 49 : 1233 - 1233
  • [37] Preliminary experience on autologous stem cell mobilization with biosimilar G-CSF
    Annaloro, C.
    Colombi, M.
    Onida, F.
    Tagliaferri, E.
    Usardi, P.
    Saporiti, G.
    Marconi, M.
    Cortelezzi, A.
    Deliliers, G. Lambertenghi
    BONE MARROW TRANSPLANTATION, 2011, 46 : S345 - S345
  • [38] Timing of G-CSF injection for effective autologous stem cell collection
    Kim, J. E.
    Suh, C. -W.
    Kim, E. K.
    Sohn, B. S.
    Park, I.
    Yoon, D. H.
    Yoo, C.
    Jang, G.
    Lee, D. H.
    Kim, S. -W.
    Lee, J. S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S301 - S302
  • [39] Pegylated G-CSF after autologous hematopoietic stem cell transplantation
    Annaloro, C.
    Usardi, P.
    Della Volpe, A.
    Onida, F.
    Basilico, C.
    Deliliers, G. Lambertenghi
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 74 - 74
  • [40] Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide
    Shaughnessy, Paul
    Islas-Ohlmayer, Miguel
    Murphy, Julie
    Hougham, Maureen
    MacPherson, Jill
    Winkler, Kurt
    Silva, Matthew
    Steinberg, Michael
    Matous, Jeffrey
    Selvey, Sheryl
    Maris, Michael
    McSweeney, Peter A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 729 - 736